Pliant Therapeutics Appoints Minnie Kuo as Chief Development Officer

Go back to Pliant Therapeutics Appoints Minnie Kuo as Chief Development Officer
(NASDAQ: PLRX) Delayed: 1.13 --0 (-0%)
Previous Close $1.13    52 Week High
Open $1.13    52 Week Low
Day High $1.13    P/E N/A 
Day Low $1.13    EPS
Volume 15,345